Cancer Biology & Medicine

Papers
(The H4-Index of Cancer Biology & Medicine is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Mitochondrial transplantation sensitizes chemotherapy to inhibit tumor development by enhancing anti-tumor immunity168
The Warburg effect drives dedifferentiation through epigenetic reprogramming91
Early-onset gastric cancer global burden profile, trends, and contributors56
Microsurgery vs. radiosurgery for the treatment of multiple metastases in the brain: a retrospective cohort study51
Phase I study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up49
Optimizing the cancer research landscape for the benefit of patients and society: A strategic perspective of the German Cancer Research Center (DKFZ) and its partnerships with university medical cente43
Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II tria39
Cancer-derived exosomal circTMEM56 enhances the efficacy of HCC radiotherapy through the miR-136-5p/STING axis38
Associations between polymorphisms in leptin and leptin receptor genes and colorectal cancer survival36
Chinese Society of Clinical Oncology Non-small Cell Lung Cancer (CSCO NSCLC) guidelines in 2024: key update on the management of early and locally advanced NSCLC36
Role of the tumor microenvironment in shaping IDH-wildtype glioma plasticity, and potential therapeutic strategies34
Cancer stem cells: a target for overcoming therapeutic resistance and relapse32
Stability and variability of molecular subtypes: comparative analysis of primary and metastatic triple-negative breast cancer29
PD-1 inhibitors provide new opportunities in conversion therapy for stage IV gastric cancer28
Immune checkpoint inhibitors: breakthroughs in cancer treatment26
ACSL3 regulates breast cancer progression via lipid metabolism reprogramming and the YES1/YAP axis25
ENO1 expression and Erk phosphorylation in PDAC and their effects on tumor cell apoptosis in a hypoxic microenvironment24
Effects of Helicobacter pylori eradication on the profiles of blood metabolites and their associations with the progression of gastric lesions: a23
Cancer cell-derived migrasomes harboring ATF6 promote breast cancer brain metastasis via endoplasmic reticulum stress-mediated disruption of the blood-brain barrier22
Advances in lung cancer screening and early detection21
Nodal peripheral T-cell lymphomas in the new classification systems21
Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China: a retrospective multicenter study21
A machine learning model to predict efficacy of neoadjuvant therapy in breast cancer based on dynamic changes in systemic immunity21
0.2160120010376